MEKPRO PHARMACEUTICALS PRIVATE LIMITED
MEKPRO PHARMACEUTICALS PRIVATE LIMITED is a TELANGANA based PRIVATE LIMITED company, Registered at dated 01-SEP-2023 on Ministry of Corporate Affairs(MCA), The Corporate Identification Number (CIN) of MEKPRO PHARMACEUTICALS PRIVATE LIMITED is U21009TS2023PTC176699 and registration number is 176699.
It has been classified as COMPANY LIMITED BY SHARES and is registered under Registar of Companies ROC HYDERABAD India. Authorized share capital of MEKPRO PHARMACEUTICALS PRIVATE LIMITED is Rs. 1500000 and its paid up capital is Rs. 500000. It aspire to serve in NA activities across the India.
Its Annual General Meeting (AGM) was lastly conducted on and as per the records of Ministry of Corporate Affairs (MCA), its balance sheet was last filed on .
MEKPRO PHARMACEUTICALS PRIVATE LIMITED has 2 directors SWAPNA MEKALA, RAVI SHANKAR MEKALA,
The registered Email address of MEKPRO PHARMACEUTICALS PRIVATE LIMITED is swapnaravishankar9@gmail.com and its registered address is H.NO 8-63/1, SRINIVASA NAGAR, QUTBULLAHPUR, HMT TOWNSHIP TIRUMALAGIRI HYDERABAD TG 500054 IN TELANGANA TELANGANA india 500054.
The current status of MEKPRO PHARMACEUTICALS PRIVATE LIMITED shows as ACTIVE
COMPANY BASIC DETAILS
MEKPRO PHARMACEUTICALS PRIVATE LIMITED
ROC HYDERABAD
ACTIVE
U21009TS2023PTC176699
01-SEP-2023
COMPANY LIMITED BY SHARES
NON-GOVT COMPANY
PRIVATE
1500000
500000
CONTACT DETAILS
500054
INDIA
H.NO 8-63/1, SRINIVASA NAGAR, QUTBULLAHPUR, HMT TOWNSHIP TIRUMALAGIRI HYDERABAD TG 500054 IN
swapnaravishankar9@gmail.com
DIRECTOR DETAILS
DIN | Director Name | Designation | Appointment Date |
---|---|---|---|
10303338 | SWAPNA MEKALA | Director | 01/09/2023 |
10303337 | RAVI SHANKAR MEKALA | Director | 01/09/2023 |
Details Updated by Companies
Quick Links
- All Registered company of TELANGANA
- Company Registered in TELANGANA
- All Registered company of HYDERABAD in TELANGANA
- Listed Company
- Company Category
- Latest Registered Company
Contact Us for Update Extra Information about your company and services.